Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 97 Records) |
| Query Trace: Primary Myelofibrosis and MPL[original query] |
|---|
| Mutation profile in Indian primary myelofibrosis patients and its clinical implications. South Asian journal of cancer 2019 9 8 (3): 186-188. Patil Vinod R, Chandrakala S, Mantri Shruti, Patil Rajesh, Wasekar Nilesh, Jijina Far |
| Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms. Hematology, transfusion and cell therapy 2019 Oct . Porto-Soares Moysés Antonio, de Oliveira Rafael Daltro, Cortopassi Gabriel Macedo, Machado-Neto João Agostinho, Palma Leonardo Carvalho, Figueiredo-Pontes Lorena Lobo |
| TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients. International journal of hematology 2019 Sep . Matsuguma Masafumi, Yujiri Toshiaki, Yamamoto Kaoru, Kajimura Yasuko, Tokunaga Yoshihiro, Tanaka Mayumi, Tanaka Yoshinori, Nakamura Yukinori, Tanizawa Yuk |
| Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms. British journal of haematology 2020 Sep . Garcia-Gisbert Nieves, Fernández-Ibarrondo Lierni, Fernández-Rodríguez Concepcion, Gibert Joan, Andrade-Campos Marcio, Arenillas Leonor, Camacho Laura, Angona Anna, Longarón Raquel, Salar Antonio, Calvo Xavier, Besses Carlos, Bellosillo Beatr |
| [Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 8 41 (7): 576-582. Tan Y X, Xu N, Huang J X, Wu W E, Liu L, Zhou L L, Liu X L, Yin C X, Xu D, Zhou |
| JAK2, CALR, and MPL Mutations in Egyptian Patients With Classic Philadelphia-negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2020 6 20 (10): e645-e651. Soliman Eman A, El-Ghlban Samah, El-Aziz Sherin Abd, Abdelaleem Abdelaleem, Shamaa Sameh, Abdel-Ghaffar Hass |
| Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis. Leukemia 2020 6 35 (2): 468-475. Barosi Giovanni, Rosti Vittorio, Catarsi Paolo, Villani Laura, Abbà Carlotta, Carolei Adriana, Magrini Umberto, Gale Robert Peter, Massa Margherita, Campanelli Ri |
| [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 9 62 (8): 1060-1069. Morishita So |
| Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International journal of environmental research and public health 2021 Jul 18 (14): . Zulkeflee Razan Hayati, Zulkafli Zefarina, Johan Muhammad Farid, Husin Azlan, Islam Md Asiful, Hassan Rosli |
| JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East. Iranian journal of pathology 2021 5 16 (2): 190-194. Safavi Moeinadin, Monabati Ahmad, Safaei Akbar, Mirtalebi Maryam Sadat, Faghih Masoum |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study. Frontiers in oncology 2021 4 11 637116. Cattaneo Daniele, Croci Giorgio Alberto, Bucelli Cristina, Tabano Silvia, Cannone Marta Giulia, Gaudioso Gabriella, Barbanti Maria Chiara, Barbullushi Kordelia, Bianchi Paola, Fermo Elisa, Fabris Sonia, Baldini Luca, Gianelli Umberto, Iurlo Alessand |
| Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India. Hematology/oncology and stem cell therapy 2021 3 15 (2): 13-20. Maddali Madhavi, Kulkarni Uday Prakash, Ravindra Niveditha, Arunachalam Arun Kumar, Venkatraman Arvind, Lionel Sharon, Manipadam Marie Therese, Devasia Anup J, Korula Anu, Fouzia N A, Abraham Aby, Srivastava Alok, George Biju, Balasubramanian Poonkuzhali, Mathews Vikr |
| Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis. International journal of hematology 2021 Jan . Morishita Soji, Ochiai Tomonori, Misawa Kyohei, Osaga Satoshi, Inano Tadaaki, Fukuda Yasutaka, Edahiro Yoko, Ohsaka Akimichi, Araki Marito, Komatsu Nor |
| [Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2021 1 41 (12): 989-995. Wu J Y, Li B, Jia Y J, Zhang P H, Xu Z F, Qin T J, Qu S Q, Pan L J, Liu J Q, Yan X, Zhang Y D, Chen J, Gong J Y, Xiao Z |
| Development of a Real-Time qPCR Assay for Detection of Common MPL Mutations in Myeloproliferative Neoplasms (MPNS). Applied biochemistry and biotechnology 2022 7 194 (12): 5907-5917. Ullah Naeem, Khan Sadiq Noor, Umair Muhammad, Khan Aamir Ali, Liu Xinhui, Khattak Aamer Ali, Yousafzai Yasar Mehmo |
| Targeted sequencing of candidate gene regions for myelofibrosis in dogs. Journal of veterinary internal medicine 2022 7 36 (4): 1237-1247. Campbell Amelia G, Seelig Davis M, Beckman Joan D, Minor Katie M, Heinrich Daniel A, Friedenberg Steven G, Modiano Jaime F, Furrow E |
| Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms. Asian Pacific journal of cancer prevention : APJCP 2022 5 23 (5): 1671-1678. Wiriyaukaradecha Kriangpol, Nimsanor Supanee, Tantirukdham Nithiphut, Tongsom Jin, Bunyoo Chakrit, Soonklang Kamonwan, Sritana Narongrit, Auewarakul Chira |
| The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in oncology 2023 8 13 1190305. Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A |
| Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN. Frontiers in genetics 2023 7 14 1198834. Jin Zhang, Kefeng Shen, Min Xiao, Jinjin Huang, Jin Wang, Yaqin Wang, Zhenya Ho |
| JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients. Hematology/oncology and stem cell therapy 2023 4 16 (3): 303-314. Shires Karen L, Rust Adriana J, Harryparsad Rushil, Coburn Justin A, Gopie Ruth |
| Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
| Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan. American journal of clinical pathology 2023 3 . Kuo Ming-Chung, Chuang Wen-Yu, Chang Hung, Lin Tung-Huei, Wu Jin-Hou, Lin Tung-Liang, Ou Che-Wei, Hung Yu-Shin, Huang Ting-Yu, Huang Ying-Jung, Wang Po-Nan, Shih Lee-Yu |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
| Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016. Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way |
| STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
| JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
| Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
| Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. Asian Pacific journal of cancer prevention : APJCP 2024 11 25 (11): 4013-4025. Somda Georgina Charlène Soro, Ghita Amalou, Sara Benchikh, Adil El Hamouchi, Hicham Charoute, Mourad Oukheda, Benani Bennani Abdelouaheb, Rachid Saile, Halima Lebrazi, Sanaa Nassereddi |
- Page last reviewed:Feb 1, 2024
- Content source: